- Kyberlife secures $3 million in funding, led by 5I Ventures, to expand its healthcare e-commerce platform across Southeast Asia.
- The Singapore-based company aims to streamline healthcare supply chains by integrating global suppliers with local institutions, reducing procurement inefficiencies by 40%.
Singapore-based healthcare e-commerce platform Kyberlife has raised $3 million in a funding round led by local venture capital firm 5I Ventures. Other investors include East Ventures, A2D Ventures, and NUS Alumni Ventures.
The investment will support Kyberlife’s regional expansion, technological advancements, and efforts to connect local healthcare institutions with global suppliers.
The company plans to expand into Indonesia by onboarding local vendors, allowing them to access cross-border business opportunities. It also aims to broaden its supplier and customer networks across Southeast Asia, including Singapore, Indonesia, and Thailand.
Kyberlife intends to introduce new product categories such as laboratory instruments and chemical reagents, facilitating research and development in clinical trials and pharmaceutical research across ASEAN. The company has set a goal of increasing its vendor portfolio tenfold over the next three years.
In addition to expansion, Kyberlife will invest in emerging technologies, including artificial intelligence, to provide personalized product recommendations and streamline procurement workflows.
"We see this investment as a crucial step in optimizing healthcare supply chains and addressing the challenges in procurement efficiency," said Kyberlife CEO Ryan James Lim.
The Asian medical market is undergoing significant growth and is expected to contribute to one-third of global sales by 2025, according to McKinsey. However, the sector faces supply chain disruptions and increasing regulatory compliance requirements, making procurement more complex.
Kyberlife aims to address these inefficiencies by digitizing manual workflows and integrating supply chain solutions. The company claims its platform reduces procurement time by an average of 40%.
Founded in 2021 by Lim and Michael Tillmann, Kyberlife operates a platform-as-a-service (PaaS) model that connects research and healthcare suppliers globally with laboratories, healthcare institutions, and research centers in Southeast Asia.
The platform currently offers 1.2 million products from 160 brands, including leading suppliers such as Merck, ZymoResearch, DKSH, Eppendorf, and Sartorius. Its customers include institutions like the National University of Singapore and Duke-NUS.
"The healthcare procurement process has historically been fragmented. Our goal is to create a seamless digital ecosystem that benefits both suppliers and healthcare providers," said Tillmann.
Kyberlife has previously attracted support from industry leaders such as Maya Hari, former global VP at Twitter, and Dr. Jeremy Lim, CEO of AMiLi. In 2022, the company secured an undisclosed amount in a pre-Series A round led by PE Global, alongside investors including James Simkins, CEO of GETZ Healthcare, and Dr. Michael Gorriz, Global Group CIO of Standard Chartered Bank.
With this latest funding, Kyberlife aims to further develop its platform and strengthen its presence in the region, positioning itself as a key player in digital healthcare procurement in Southeast Asia.
Edited by Harshajit Sarmah
